HN2011001597A - Sintesis de morfina -6-glucoronido o de uno de sus derivados - Google Patents

Sintesis de morfina -6-glucoronido o de uno de sus derivados

Info

Publication number
HN2011001597A
HN2011001597A HN2011001597A HN2011001597A HN2011001597A HN 2011001597 A HN2011001597 A HN 2011001597A HN 2011001597 A HN2011001597 A HN 2011001597A HN 2011001597 A HN2011001597 A HN 2011001597A HN 2011001597 A HN2011001597 A HN 2011001597A
Authority
HN
Honduras
Prior art keywords
grupo
glucoronide
derivatives
group
morfina
Prior art date
Application number
HN2011001597A
Other languages
English (en)
Spanish (es)
Inventor
Dlubala Alain
Ripoche Isabelle
Trecant Claire
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HN2011001597A publication Critical patent/HN2011001597A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HN2011001597A 2008-12-10 2011-06-09 Sintesis de morfina -6-glucoronido o de uno de sus derivados HN2011001597A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806948A FR2939436B1 (fr) 2008-12-10 2008-12-10 Synthese de morphine-6-glucuronide ou de l'un de ses derives

Publications (1)

Publication Number Publication Date
HN2011001597A true HN2011001597A (es) 2013-09-09

Family

ID=40996840

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2011001597A HN2011001597A (es) 2008-12-10 2011-06-09 Sintesis de morfina -6-glucoronido o de uno de sus derivados

Country Status (30)

Country Link
US (1) US8258298B2 (https=)
EP (1) EP2376496B1 (https=)
JP (1) JP5619768B2 (https=)
KR (1) KR20110091534A (https=)
CN (1) CN102307876B (https=)
AR (1) AR074513A1 (https=)
AU (1) AU2009326906B2 (https=)
BR (1) BRPI0923238A2 (https=)
CA (1) CA2746428A1 (https=)
CL (1) CL2011001398A1 (https=)
CO (1) CO6390060A2 (https=)
CR (1) CR20110307A (https=)
EA (1) EA201170790A1 (https=)
EC (1) ECSP11011100A (https=)
ES (1) ES2470666T3 (https=)
FR (1) FR2939436B1 (https=)
HN (1) HN2011001597A (https=)
IL (1) IL213379A0 (https=)
MA (1) MA32950B1 (https=)
MX (1) MX337925B (https=)
MY (1) MY152276A (https=)
NI (1) NI201100116A (https=)
NZ (1) NZ593342A (https=)
PE (1) PE20110836A1 (https=)
SG (1) SG172069A1 (https=)
TN (1) TN2011000243A1 (https=)
TW (1) TW201033218A (https=)
UA (1) UA103643C2 (https=)
WO (1) WO2010067007A2 (https=)
ZA (1) ZA201104657B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10807995B2 (en) 2018-07-13 2020-10-20 Alkermes Pharma Ireland Limited Thienothiophene compounds for long-acting injectable compositions and related methods
US10799496B2 (en) 2018-07-13 2020-10-13 Alkermes Pharma Ireland Limited Naphthylenyl compounds for long-acting injectable compositions and related methods
US10975099B2 (en) 2018-11-05 2021-04-13 Alkermes Pharma Ireland Limited Thiophene compounds for long-acting injectable compositions and related methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766188A (en) * 1971-06-28 1973-10-16 Yamanouchi Pharma Co Ltd Carbonyldioxymorphinan derivatives
GB9116909D0 (en) * 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
DE69815336T2 (de) 1997-04-14 2004-05-06 Ufc Ltd. Morphin-derivate
PL194362B1 (pl) * 1998-06-06 2007-05-31 Cenes Ltd Sposób syntezy beta-anomeru morfino-6-glukuronidui zastosowanie związków
GB9914382D0 (en) * 1999-06-21 1999-08-18 Ufc Limited New process for the manufacture of morphine-6-glucuronide and its analogues and also to a manufacture of new intermediaries
KR20040014544A (ko) * 2001-06-05 2004-02-14 컨트롤 딜리버리 시스템즈 인코포레이티드 서방 진통제 화합물
US6740641B2 (en) * 2001-07-27 2004-05-25 Euro-Celtique, S.A. Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain
KR20050008658A (ko) * 2002-03-19 2005-01-21 마이클 홀릭 아포모르핀의 글리코시드 및 오르토에스테르 글리코시드유도체들, 유사체들 및 그것의 용도
FR2864082B1 (fr) 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur

Also Published As

Publication number Publication date
SG172069A1 (en) 2011-07-28
ECSP11011100A (es) 2011-07-29
WO2010067007A3 (fr) 2011-07-07
ES2470666T3 (es) 2014-06-24
CO6390060A2 (es) 2012-02-29
MY152276A (en) 2014-09-15
UA103643C2 (ru) 2013-11-11
PE20110836A1 (es) 2011-11-25
TW201033218A (en) 2010-09-16
CN102307876B (zh) 2014-12-10
FR2939436A1 (fr) 2010-06-11
JP5619768B2 (ja) 2014-11-05
EA201170790A1 (ru) 2011-12-30
NZ593342A (en) 2013-07-26
KR20110091534A (ko) 2011-08-11
CR20110307A (es) 2011-09-21
EP2376496A2 (fr) 2011-10-19
AR074513A1 (es) 2011-01-19
AU2009326906A1 (en) 2011-06-30
FR2939436B1 (fr) 2010-12-17
AU2009326906B2 (en) 2016-05-26
CA2746428A1 (fr) 2010-06-17
TN2011000243A1 (fr) 2012-12-17
CN102307876A (zh) 2012-01-04
JP2012511551A (ja) 2012-05-24
ZA201104657B (en) 2012-09-26
HK1163096A1 (en) 2012-09-07
WO2010067007A2 (fr) 2010-06-17
BRPI0923238A2 (pt) 2016-01-26
US20110275820A1 (en) 2011-11-10
CL2011001398A1 (es) 2011-10-28
MA32950B1 (fr) 2012-01-02
IL213379A0 (en) 2011-07-31
EP2376496B1 (fr) 2014-03-12
MX2011006264A (es) 2011-11-04
NI201100116A (es) 2011-12-14
MX337925B (es) 2016-03-28
US8258298B2 (en) 2012-09-04

Similar Documents

Publication Publication Date Title
CY1121776T1 (el) C17-αλκανοδιυλιο και παραγωγα αλκενοδιυλιου του ολεανολικου οξεος και μεθοδοι χρησης αυτων
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
EA200702614A1 (ru) Способы получения 4-(бифенилил)азетидин-2-оналкилфосфиновых кислот
UY31523A1 (es) Procedimiento para la preparacion de esteres alquilicos de acidos grasos
NZ592497A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
WO2009129545A8 (en) Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
CR20110491A (es) Inhibidores de epoxicetona proteasa de tripéptidos cristalinos
WO2008022777A3 (de) Verfahren zum herstellen von 3-dihalomethyl-pyrazol-4-carbonsäurederivaten
NZ603268A (en) Process for synthesizing oxidized lactam compounds
CY1115043T1 (el) Φαρμακευτικο σκευασμα
BRPI0817747A8 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
MY150280A (en) Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
CL2011000296A1 (es) Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados.
MA33948B1 (fr) Dérivés d'acide 3-hétéroaroylamino-propionique substitues par oxygène et leur utilisation en tant qu'agents pharmaceutiques.
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
MX2012001411A (es) Proceso para la preparacion de derivados de acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico.
HN2011001597A (es) Sintesis de morfina -6-glucoronido o de uno de sus derivados
CL2011000093A1 (es) Compuestos derivados de un ester piperidinilico del acido bifenil-2-ilcarbamico; composicion farmaceutica; combinacion farmaceutica; y su uso para broncoconstriccion, enfermedades obstructivas o inflamatorias de las vias respiratorias.
BRPI0814115B8 (pt) composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto
IN2014MN00971A (https=)
AR084209A1 (es) Metodo para la sintesis de derivados de aminociclohexanona sustituidos
CO6612175A2 (es) Metodo para producir 4,6-dialcoxi-2-cianometil-pirimidina e intermediarios sinteticos de esta
IN2012DN03819A (https=)
MX2011010934A (es) Proceso para la preparacion de un ester del acido bifenil-2-il-carbamico.